NASDAQ : BLFS
BioLife Solutions, Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 38.61 USD (At close: Oct 5, 2026) · Market cap 1.89B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.89B |
| Enterprise Value | 1.79B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 48.91M |
| Shares Outstanding | 48.91M |
| Shares Change (YoY) | +5.54% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 2.93% |
| Owned by Institutions (%) | 86.86% |
| Float | 40.12M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 33.19 |
| Forward PE | 134.67 |
| PS Ratio | 17.70 |
| Forward PS | 15.25 |
| PB Ratio | 4.49 |
| P/TBV Ratio | 9.09 |
| P/FCF Ratio | 247.38 |
| P/OCF Ratio | 111.89 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 30.89 |
| EV / Sales | 16.79 |
| EV / EBITDA | 259.56 |
| EV / EBIT | 1,025.16 |
| EV / FCF | 234.63 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 9.69 |
| Quick Ratio | 6.67 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 1.48 |
| Debt / FCF | 2.06 |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 12.83% |
| Return on Assets (ROA) | 0.26% |
| Return on Invested Capital (ROIC) | 0.27% |
| Return on Capital Employed (ROCE) | 0.40% |
| Weighted Average Cost of Capital (WACC) | 14.16% |
| Revenue Per Employee | $688,310 |
| Profits Per Employee | $374,071 |
| Employee Count | 155 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 1.23 |
Taxes
| Measure | Value |
|---|
| Income Tax | -42.38M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.82 |
| 52-Week Price Change | +45.21% |
| 50-Day Moving Average | 35.70 |
| 200-Day Moving Average | 26.62 |
| Relative Strength Index (RSI) | 60.55 |
| Average Volume (20 Days) | 1,210,830 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3.88M |
| Short Previous Month | 3.93M |
| Short % of Shares Out | 7.94% |
| Short % of Float | 9.68% |
| Short Ratio (days to cover) | 4.54 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 106.69M |
| Gross Profit | 67.87M |
| Operating Income | 1.75M |
| Pretax Income | 6.83M |
| Net Income | 57.98M |
| EBITDA | 6.90M |
| EBIT | 1.75M |
| Earnings Per Share (EPS) | $1.16 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 82.42M |
| Total Debt | 15.74M |
| Net Cash | 97.33M |
| Net Cash Per Share | $1.99 |
| Equity (Book Value) | 420.00M |
| Book Value Per Share | 8.59 |
| Working Capital | 121.25M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 16.88M |
| Capital Expenditures | -9.24M |
| Depreciation & Amortization | 5.15M |
| Net Borrowing | -10.00M |
| Free Cash Flow | 7.63M |
| FCF Per Share | $0.16 |
Margins
| Measure | Value |
|---|
| Gross Margin | 63.61% |
| Operating Margin | 1.64% |
| Pretax Margin | 6.40% |
| Profit Margin | 54.35% |
| EBITDA Margin | 6.47% |
| EBIT Margin | 1.64% |
| FCF Margin | 7.15% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -5.54% |
| Shareholder Yield | -5.54% |
| Earnings Yield | 3.07% |
| FCF Yield | 0.40% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $31.29 |
| Price Target Difference | -18.96% |
| Analyst Consensus | Hold |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 19.55% |
| EPS Growth Forecast (3Y) | 97.25% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jan 29, 2014 |
| Split Type | Reverse |
| Split Ratio | 1:14 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 24.76 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |